Viraent 1 Tablet contains Entecavir 1mg, a potent antiviral agent indicated for the treatment of chronic Hepatitis B virus (HBV) infection. It works by blocking HBV DNA polymerase, reducing viral multiplication, lowering viral load, and protecting liver cells from further damage.
Entecavir is commonly prescribed in cases of elevated liver enzymes, cirrhosis, and long-term hepatitis management. Its high efficacy and safety profile make it a preferred choice among hepatologists and gastroenterologists.
Viraent 1 Tablet belongs to the antiviral and hepatology therapy segment, ensuring steady prescription demand in chronic care treatment.
For PCD pharma franchise partners, wholesalers, and exporters, Viraent 1 Tablet offers a strong market advantage due to continuous therapy requirements and high medical relevance. It is available for bulk supply, private label third-party manufacturing, monopoly-based PCD franchise, institutional supply, and export.